Zydus Cadila announced on Saturday that they will start producing one crore doses of Covid-19 vaccine by October. Zydus Cadila MD Dr Sharvil Patel also broke the news to India Today that the company will now apply to start the trial of its Covid-19 vaccine in children of age group 3-12.
ZyCoV-D is a three-dose, needle-free vaccine, and is also the world's first plasmid DNA-based medicine. Developed in partnership with the Department of Biotechnology, it is India's second locally developed vaccine to receive EUA after Bharat Biotech's Covaxin
"The vaccines for children should come out now because trials in India are already there in the vaccines which are available in India, the Bharat Biotech trial is in the final phase by September we will have the data," Dr Guleria told ANI